Atrium Therapeutics, Inc.
NASDAQ:RNABiotechnology
Healthcare
$6.64 +1.28%
+$0.16 today
- Market cap
- $143.23M
- Beta
- 0.42
- P/E (TTM)
- -3.3
- EPS (TTM)
- -$3.78
52W Low $11.40High $16.77
Volume 0.22M
Average 0.35M
RNA Common Stock Issued
Cash raised by issuing new shares.
Atrium Therapeutics, Inc.NASDAQ: RNA
Common Stock Issued · Q1 FY2026 · quarter ended Mar 2026
Common stock issued of $0 in Q1 FY2026
Q1 FY2026 common stock issued was $0.
Context
- Common stock issued amounted to 0.0% of revenue in FY2025.
Sources:Cash FlowText generated from reported figures; not investment advice.
Common Stock Issued history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- —
| Period | Period end | Common Stock Issued | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | — |
Sign in to see up to ten periods of history.Sign in
Common Stock Issued vs competitors
How RNA compares with its peers on the latest reported figures
No competitor Common Stock Issued figures are available to compare.
Cash Flow Statement
USD
Atrium Therapeutics, Inc.
NASDAQ:RNA
Intrinsic Alpha fair value
Locked
Current Price
$6.64
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.